Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PTP4A3 | O75365 | 2/20 | 0.36 |
| ▸ | PTP4A1 | Q93096 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Styrene SCHEMBL1255712 | 0.96 | CYP3A4 (0.40) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| Styrene SCHEMBL7698100 | 0.86 | MAPT (0.40) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| SCHEMBL17746697 | 0.85 | CASP1 (0.41) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| Styrene SCHEMBL3958178 | 0.84 | KDM4E (0.39) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| Styrene SCHEMBL8844775 | 0.84 | KMT2A (0.48) | MAPTMEN1KMT2AMAPK1KDM4E | |
| Styrene SCHEMBL327472 | 0.83 | CYP3A4 (0.44) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| SCHEMBL8047550 | 0.82 | MAPT (0.39) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| Styrene SCHEMBL4566873 | 0.81 | CYP3A4 (0.39) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| Styrene SCHEMBL327788 | 0.81 | CYP3A4 (0.38) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| Acrylonitrile SCHEMBL9067820 | 0.80 | CYP3A4 (0.44) | CYP3A4MAPTMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10358563-B2 | Core-shell metal nanoparticle composite | XEROX CORPORATION (US) | 2019-07-23 | — | — | US | disclosed |
| US-20170233535-A1 | CORE-SHELL METAL NANOPARTICLE COMPOSITE | Genesee Valley Innovations, LLC | 2017-08-17 | — | — | US | disclosed |
| US-9718970-B2 | Core-shell metal nanoparticle composite | XEROX CORPORATION (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160215104-A1 | CORE-SHELL METAL NANOPARTICLE COMPOSITE | Genesee Valley Innovations, LLC | 2016-07-28 | — | — | US | disclosed |
| US-9164410-B2 | Toner compositions for single component development system | XEROX CORPORATION (US) | 2015-10-20 | — | — | US | disclosed |
| US-9075329-B2 | Emulsion aggregation toners with improved particle size distribution | XEROX CORPORATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-9023567-B2 | Polymerized charge enhanced spacer particle | XEROX CORPORATION (US) | 2015-05-05 | — | — | US | disclosed |
| US-8986917-B2 | Toner composition having improved charge characteristics and additive attachment | XEROX CORPORATION (US) | 2015-03-24 | — | — | US | disclosed |
| US-20150004536-A1 | TONER COMPOSITIONS FOR SINGLE COMPONENT DEVELOPMENT SYSTEM | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2015-01-01 | — | — | US | disclosed |
| US-8889583-B2 | Catalyst production | XEROX CORPORATION (US) | 2014-11-18 | — | — | US | disclosed |
| EP-1832606-B1 | Toner composition and methods | XEROX CORP (US) | 2009-07-29 | — | — | EP | disclosed |
| US-7541126-B2 | Toner composition | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7476480-B2 | Processes for producing toner by treatment with enzyme | XEROX CORPORATION (US) | 2009-01-13 | — | — | US | disclosed |
| US-20070248902-A1 | Toner composition having dual wax | XEROX CORPORATION | 2007-10-25 | — | — | US | disclosed |
| EP-1832606-A1 | toner composition and methods | Xerox Corporation (US) | 2007-09-12 | — | — | EP | disclosed |
| US-20070207400-A1 | Toner composition and methods | XEROX CORPORATION | 2007-09-06 | — | — | US | disclosed |
| US-20070190441-A1 | Toner composition | XEROX CORPORATION | 2007-08-16 | — | — | US | disclosed |
| US-20070134579-A1 | Processes for producing toner by treatment with enzyme | XEROX CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-20070134576-A1 | Toner composition | XEROX CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-20070037086-A1 | Toner composition | XEROX CORPORATION | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233535-A1 | CORE-SHELL METAL NANOPARTICLE COMPOSITE | PCBP1, PUF60, SEPTIN9 | CYP3A4 4136/4885MAPT 216/4885MEN1 1447/4885 |
| US-20160215104-A1 | CORE-SHELL METAL NANOPARTICLE COMPOSITE | PCBP1, PUF60, SEPTIN9 | CYP3A4 4136/4885MAPT 216/4885MEN1 1447/4885 |
| US-10358563-B2 | Core-shell metal nanoparticle composite | PCBP1, PUF60, SEPTIN9 | CYP3A4 4136/4885MAPT 216/4885MEN1 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.